Preclinical studies show smoothened agonists like SAG can repair the blood-brain barrier, reduce inflammation, and improve neurological function after traumatic brain injury.
← News
After TBI, smoothened agonists cut swelling, inflammation, and neurological deficits
1 Million TBIs treated annually in US
50,000 TBI-related deaths annually in US